Human hepatic alcohol dehydrogenase and human erythrocyte catalase do not metabolize the cytochrome P-4502E1 substrate, chlorzoxazone

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 3, 1996, Pages 533-537

  McCarver May, D Gail ^a   Durisin, Lubica ^b  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b NONE

Author keywords

Alcohol Dehydrogenase; Catalase; Chlorzoxazone; Cytochrome P 4502E1; Ethanol Metabolism

Indexed keywords

ALCOHOL DEHYDROGENASE; CATALASE; CHLORZOXAZONE; CYTOCHROME P450;

ALCOHOL METABOLISM; ALCOHOLISM; ARTICLE; DRUG METABOLISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; LIVER MICROSOME METABOLISM; MICHAELIS MENTEN KINETICS; PRIORITY JOURNAL;

EID: 0029933505     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01088.x     Document Type: Article

References (20)

1. Peter R, Bocker R, Beaune PH, Iwasaki M, Guengerich FP, Yang CS: Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem Res Toxicol 3:566-573, 1990
2. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
3. Bosron WF, Li TK, Vallee BL: Heterogeneity and new molecular forms of human liver alcohol dehydrogenase. Biochem Biophys Res Commun 91:1549-1555, 1979
4. 3 alcohol dehydrogenase. Biochemistry 28:6810-6815, 1989
5. Yasmineh WG, Chung MY, Caspers JI: Determination of serum catalase activity on a centrifugal analyzer by an NADP/NADPH coupled enzyme reaction system. Clin Biochem 25:21-27, 1992
6. Lieber CS, DeCarli LM: Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science 162:917-918, 1968
7. Mezey E: Ethanol metabolism and ethanol-drug interactions. Biochem Pharmacol 25:869-875, 1976
8. Thurman RG, Handler JA: Cytochrome P450IIE1 plays a minor role in alcohol metabolism. Drug Metab Rev 20:679-688, 1989
9. Rognstad R: Isotopic probes into pathways of ethanol metabolism. Arch Biochem Biophys 163:544-551, 1974
10. Vind C, Grunnet N: Contribution of non-ADH pathways to ethanol oxidation in hepatocytes from fed and hyperthyroid rats. Biochem Pharmacol 34:655-661, 1985
11. Salaspuro MP, Shaw S, Jayatilleke E, Ross WA, Lieber CS: Attenuation of the ethanol-inducible hepatic redox change after chronic alcohol consumption in baboons: Metabolic consequences in vivo and in vitro. Hepatology 1:33-38, 1981
12. Lieber CS, DeCarli LM: Hepatic microsomal ethanol oxidizing system: in vitro characteristics and adaptive properties in vivo. J Biol Chem 245:2505-2512, 1970
13. Watanabe J, Hayashi SI, Nakachi K, Imai K, Suda Y, Sekine T, Kawajiri K: PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res 18:7194, 1991
14. Kelsell DP, Wolf CR, Spur NK: An XmnI RFLP detected with a probe for the CYP2E gene locus on chromosome 10. Nucleic Acids Res 18:3111, 1990
15. Uematsu F, Kikucchi H, Motomiya M, Abe T, Ishioka C, Kanamaru R, Sagami I, Watanabe M: Human cytochrome P450IIE1 gene: DraI polymorphisms and susceptibility to cancer. Tohoku J Exp Med 168:113-117, 1992
16. Zand R, Nelson SD, Slattery JT, Thummel KE, Kalhorn TF, Adams SP, Wright JM: Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans. Clin Pharmacol Ther 54:142-149, 1993
17. O'Shea D, Davis SN, Kim RB, Wilkinson GR: Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: A putative probe of CYP2E1 activity. Clin Pharmacol Ther 56:359-367, 1994
18. Carriere V, Goasduff T, Ratanasavanh D, Morel F, Gautier JC, Guillouzo A, Beaune P, Berthou F: Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem Res Toxicol 6:852-857, 1992
19. Conney AH, Burns JJ: Physiological disposition and metabolic fate of chlorzoxazone (Paraflex) in man. Pharmacol Exp Ther 128:340-343, 1960
20. Girre C, Lucas D, Menez C, Dally S, Menez J-F: Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem Pharmacol 47:1503-1508, 1994